Clinical Study

Clinical Experience with the PillCam Patency Capsule prior to Video Capsule Endoscopy: A Real-World Experience

Table 1

Demographic and clinical characteristics of the study population: the main indications for the planned VCE were suspected Crohn’s disease of the small intestine or gastrointestinal bleeding. All 38 included patients had at least one risk factor for a capsule retention.

Parameter

Age [years]61,5 14–88
Sex [male/female]17/21
Indication for VCE
 Suspected CD of the small bowel10 (26%)
 Anemia/gastrointestinal bleeding26 (68%)
 Suspected tumor2 (5%)
Documented risk factor for capsule retention
 One documented risk factor for capsule retention8 (21%)
 More than one documented risk factor for capsule retention30 (79%)
 Suspected or known Crohn’s disease11 (29%)
 Previous abdominal surgery21 (55%)
  Multiple previous abdominal surgeries 11 (29%)
 Previous subileus or ileus2 (5%)
 Suspected tumor in imaging 4 (11%)
 High dose and/or longtime NSAID use8 (21%)

VCE: video capsule endoscopy, CD: Crohn’s disease, and NSAID: nonsteroidal anti-inflammatory drug.